Tatsuhiko Imaoka Selected Research

Tatsuhiko Imaoka Research Topics

Disease

28	Neoplasms (Cancer) 08/2023 - 10/2003
17	Carcinogenesis 09/2023 - 11/2004
14	Carcinoma (Carcinomatosis) 10/2022 - 09/2007
13	Breast Neoplasms (Breast Cancer) 03/2023 - 05/2006
3	Second Primary Neoplasms (Neoplasms, Second) 10/2019 - 04/2011
3	Lymphoma (Lymphomas) 01/2013 - 10/2003
1	Adenocarcinoma 08/2023
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 08/2023
1	Glioma (Gliomas) 06/2023
1	Mesothelioma 04/2023
1	Malignant Mesothelioma 04/2023
1	Ovarian Neoplasms (Ovarian Cancer) 04/2023
1	Body Weight (Weight, Body) 03/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Iron Overload 01/2022
1	Obesity 01/2016
1	Radiation-Induced Neoplasms (Neoplasms, Radiation Induced) 02/2013
1	Colorectal Neoplasms (Colorectal Cancer) 04/2011
1	Neoplasm Metastasis (Metastasis) 09/2007
1	Colitis 01/2006
1	Colonic Neoplasms (Colon Cancer) 01/2006
1	Adenomyosis 11/2003
1	T-Cell Lymphoma (Lymphoma, T Cell) 10/2003

Drug/Important Bio-Agent (IBA)

11	CarcinogensIBA 03/2023 - 06/2005
8	Proteins (Proteins, Gene)FDA Link 08/2023 - 06/2005
6	CarbonIBA 10/2019 - 10/2003
5	DNA (Deoxyribonucleic Acid)IBA 04/2023 - 08/2010
5	IonsIBA 10/2019 - 10/2003
4	Hormones (Hormone)IBA 01/2021 - 07/2011
3	Estrogen ReceptorsIBA 10/2022 - 07/2011
2	Azithromycin (Zithromax)FDA LinkGeneric 09/2023 - 08/2023
2	Messenger RNA (mRNA)IBA 08/2023 - 08/2010
2	Nonsense Codon (Nonsense Mutation)IBA 08/2023 - 04/2010
2	Drinking WaterIBA 08/2023 - 01/2006
2	CateninsIBA 08/2023 - 05/2023
2	IronIBA 04/2023 - 01/2022
2	A-Form DNA (A-DNA)IBA 10/2022 - 01/2013
2	Insulin (Novolin)FDA Link 03/2022 - 01/2016
2	LeptinIBA 03/2022 - 01/2016
2	Phenobarbital (Luminal)FDA Link 01/2021 - 03/2019
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 07/2011
2	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 04/2014 - 11/2011
2	beta CateninIBA 02/2006 - 01/2006
1	Cyclin D1IBA 08/2023
1	MacrolidesIBA 08/2023
1	Antineoplastic Agents (Antineoplastics)IBA 08/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2023
1	arseniteIBA 06/2023
1	AsbestosIBA 04/2023
1	Serpentine Asbestos (Chrysotile)IBA 04/2023
1	CholesterolIBA 03/2022
1	Triglycerides (Triacylglycerol)IBA 03/2022
1	ferric nitrilotriacetateIBA 01/2022
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Progesterone FDA LinkGeneric 01/2018
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2018
1	Polycomb Repressive Complex 2IBA 01/2018
1	Angiotensin IIIBA 01/2016
1	candesartanIBA 01/2016
1	AngiotensinsIBA 01/2016
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2016
1	ReninIBA 01/2016
1	Losartan (Cozaar)FDA LinkGeneric 01/2016
1	Angiotensin Receptor AntagonistsIBA 01/2016
1	Small Interfering RNA (siRNA)IBA 05/2014
1	RNA (Ribonucleic Acid)IBA 02/2013
1	MicroRNAs (MicroRNA)IBA 02/2013
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 01/2013
1	Peptide Initiation Factors (Initiation Factor)IBA 11/2011
1	Protein Isoforms (Isoforms)IBA 11/2011
1	Sirolimus (Rapamycin)FDA Link 11/2011
1	Therapeutic UsesIBA 11/2011
1	TOR Serine-Threonine KinasesIBA 11/2011
1	benzocycloheptapyridineIBA 11/2011
1	LigandsIBA 07/2011
1	Estrogens (Estrogen)FDA Link 07/2011
1	ErbB Receptors (EGF Receptor)IBA 07/2011
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 04/2010
1	Untranslated RNA (Noncoding RNA)IBA 07/2008
1	Estrogen Receptor alphaIBA 09/2007
1	Dextrans (Dextran)FDA Link 01/2006
1	Dihydrotachysterol (AT 10)IBA 01/2006
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2006
1	Codon (Codons)IBA 06/2005
1	thymosin beta(4)IBA 11/2003
1	T-Lymphocyte Differentiation Antigens (Antigens, Differentiation, T Lymphocyte)IBA 10/2003

Therapy/Procedure

7	Radiotherapy 06/2023 - 04/2011
3	Therapeutics 01/2022 - 01/2010
2	Aftercare (After-Treatment) 01/2021 - 03/2013
1	Intraperitoneal Injections 10/2022
1	Heavy Ion Radiotherapy 01/2010